Diana Encalada Soto
Research Subjects
Research Interests
Diana Encalada Soto has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Adela Cope
Division of Minimally Invasive Gynecologic Surgery
1 shared publicationIsabel C. Green
Division of Minimally Invasive Gynecologic Surgery
1 shared publicationSarah Rassier
Division of Minimally Invasive Gynecologic Surgery
1 shared publicationTatnai Burnett
Division of Minimally Invasive Gynecologic Surgery
1 shared publicationZaraq Khan
Division of Minimally Invasive Gynecologic Surgery
1 shared publication
Latest Publications
- 1 August 2022
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 34 (4) , 210-219
Endometriosis biomarkers of the disease: an update
Purpose of review: Endometriosis is a complex benign gynaecologic condition with heterogenous presentations and a large impact on the global healthcare system and on the quality of life for millions of women. Currently, the gold standard for diagnosis involves direct visualization of lesions during surgery confirmed by histopathological diagnosis, resulting in an average delay in its initial diagnosis of 8–10 years. Therefore, the search for noninvasive diagnostic testing options has been subject to a large body of research. Recent findings: Multiple potential biomarkers have been explored for noninvasive testing for endometriosis, including glycoproteins, inflammatory cytokines, immunological molecules, angiogenesis markers, hormones, micro RNAs (miRNAs), proteomics, metabolomics, genomics and the microbiome. Summary: Although there are challenges to consider, areas for real promise and advancement in the noninvasive diagnosis of endometriosis are currently being explored with real promise in the area of miRNAs, proteomics, metabolomics, genomics and the microbiome.
- 1 August 2022
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 34 (4) , 210-219
Endometriosis biomarkers of the disease: an update
Purpose of review: Endometriosis is a complex benign gynaecologic condition with heterogenous presentations and a large impact on the global healthcare system and on the quality of life for millions of women. Currently, the gold standard for diagnosis involves direct visualization of lesions during surgery confirmed by histopathological diagnosis, resulting in an average delay in its initial diagnosis of 8–10 years. Therefore, the search for noninvasive diagnostic testing options has been subject to a large body of research. Recent findings: Multiple potential biomarkers have been explored for noninvasive testing for endometriosis, including glycoproteins, inflammatory cytokines, immunological molecules, angiogenesis markers, hormones, micro RNAs (miRNAs), proteomics, metabolomics, genomics and the microbiome. Summary: Although there are challenges to consider, areas for real promise and advancement in the noninvasive diagnosis of endometriosis are currently being explored with real promise in the area of miRNAs, proteomics, metabolomics, genomics and the microbiome.